TNON · Tenon Medical, Inc.

On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 49.38% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 24.69% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 1,041 restricted stock units ("RSUs") granted to the reporting person on November 5, 2024 into 1,041 shares of common stock of the Issuer on March 3, 2026.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

These shares were sold to pay tax liability associated with the vesting of RSUs.

Represents conversion of 10,732 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 583 RSUs granted to the reporting person on May 8, 2024 into 583 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 10,732 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 10,732 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 58,987 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 126,577 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 126,577 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 583 RSUs granted to the reporting person on May 8, 2024 into 583 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 140,936 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 140,936 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 10,732 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 140,936 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 140,936 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 64,479 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 64,479 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 64,479 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 64,479 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 10,732 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 58,987 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 58,987 shares of common stock of the Issuer on January 1, 2026.

Represents conversion of 10,732 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,732 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of 126,577 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 126,577 shares of common stock of the Issuer on January 1, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.

On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.

On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.

On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 101,167 shares of common stock of the Issuer and warrants to purchase up to 101,167 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.

On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 101,167 shares of common stock of the Issuer and warrants to purchase up to 101,167 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.

On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.

Represents conversion of 2,083 restricted stock units ("RSUs") into 2,083 shares of common stock of the Issuer on September 3, 2025.

Each RSU represents a contingent right to receive one share of common stock of the Issuer.

N/A

Represents conversion of 2,083 restricted stock units ("RSUs") into 2,083 shares of common stock of the Issuer on September 3, 2025.

Represents conversion of a portion of restricted stock units ("RSUs") granted to the reported person on May 12, 2022 into the shares of common stock on one-for-one basis (as adjusted for 1-for-10 reverse stock split effected by the Issuer on November 2, 2023 and for 1-for-8 reverse stock split effected by the Issuer on September 6, 2024).

Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of a portion of restricted stock units ("RSUs") granted to the reported person on May 12, 2022 into the shares of common stock on one-for-one basis (as adjusted for 1-for-10 reverse stock split effected by the Issuer on November 2, 2023 and for 1-for-8 reverse stock split effected by the Issuer on September 6, 2024).

Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Represents conversion of a portion of restricted stock units ("RSUs") granted to the reported person on May 12, 2022 into the shares of common stock on one-for-one basis (as adjusted for 1-for-10 reverse stock split effected by the Issuer on November 2, 2023 and for 1-for-8 reverse stock split effected by the Issuer on September 6, 2024).

Represents conversion of a portion of restricted stock units ("RSUs") granted to the reported person on May 12, 2022 into the shares of common stock on one-for-one basis (as adjusted for 1-for-10 reverse stock split effected by the Issuer on November 2, 2023 and for 1-for-8 reverse stock split effected by the Issuer on September 6, 2024).

Represents a grant of 6,250 RSUs of the Issuer pursuant to Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. Each RSU will vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) as follows: 2,083 RSUs on September 3, 2025; 1,041 RSUs on each of March 3, 2026, September 3, 2026, and March 3, 2027; and 1,044 on September 3, 2027.

Each RSU represents a contingent right to receive one share of common stock of the Issuer.

N/A

Represents conversion of a portion of restricted stock units ("RSUs") granted to the reported person on May 12, 2022 into the shares of common stock on one-for-one basis (as adjusted for 1-for-10 reverse stock split effected by the Issuer on November 2, 2023 and for 1-for-8 reverse stock split effected by the Issuer on September 6, 2024).

Each RSU represents a contingent right to receive one share of common stock of the Issuer.